SENDD
The AI system that detects infant’s neurological disorders
How it Works
Intro To SENDD
SENDD stands for System for Early Neurological Deviation Detection and is a unique AI solution.
Our Target
SENDD is intended to target children in the early infancy stage (2-3 months) who may be at risk of neurodevelopmental disorders.
Purpose
SENDD is meant for detecting infants at high risk of neurodevelopmental disorders or expected normal outcomes in a group of neuro-risky children.
The SENDD System
SENDD is the result of a unique collaboration between the Polyclinic dr. Sabol and AI Computer Vision specialist TIS Group based in Croatia.
Partly funded by European Research Grant for research and development, research teams have developed a digital system for early detection of potential neurodevelopmental disorders in infants.
- Amyotrophic lateral sclerosis
- Multiple sclerosis
- Parkinson's disease
- Alzheimer's disease
- Huntington's disease
- Multiple system atrophy
- Prion diseases.
For parents; early detection of neuro risk in infancy, non-invasive methodology and analysis available via smartphone.
For hospitals or clinicians; avoid/reduce doctors time observing hundreds of fidgety movements, revenue opportunities, and recruitment tool.